Novel Therapies Symposium

The Novel Therapies Symposium showcases clinical trials on emerging compounds and new medical devices, including proof-of-concept and post-marketing studies, with a focus on data from human trials – particularly phase II and III. We aim to highlight studies which have not yet been published as journal articles.

Submission status

It is no longer possible to submit a lecture proposal.
The deadline was 30 April 2026.

Review

All submissions will be reviewed by the Scientific Programme Committee (SPC) for acceptance, the outcome of the review will be communicated before 18 June 2026.     

Proposals

Submissions of proposals were invited on advances in medications and medical devices, focusing on the application of new drugs and technologies in clinical settings.

Building on last year’s expansion, submissions featuring new medical devices, such as neurostimulation and other cutting-edge technologies, were also welcomed.

Further information

Selected speakers will receive:

  • Approximately 15 minutes to present their research
  • Reimbursement of travel and accommodation costs 

We accepted submissions from both academia and industry.